Publikationen – Maiwald

22 Nov 2024 -

Interview IAM Strategy 300 Global Leaders, 2024

This year, IAM has once again invited leading experts in the field of intellectual property to provide valuable insights, highlight key experiences and share their views on the current market situation. We are proud that t...

21 Oct 2024 -

EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024

Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for medicinal products.

21 Oct 2024 -

Year Two – The Unitary Patent and the Unified Patent Court at a Glance, AIPLA Chemical Practice Chronicles Newsletter, Vol. 12 Issue 2, 2024

We can now look back on a quite successful first year of the new European patent and court system. Now well into its second year, the Unitary Patent (UP) continues to grow in popularity and the Unified Patent Court (UPC) is proving itself to be a truly pan-European court. Bo...

21 Oct 2024 -

Patenting medical treatments in the US and Europe – a guide for practitioners, Managing IP 2024

Dr. Eva Ehlich & Dr. Anja Fux from Maiwald and Eldora Ellison, Paul Calvo & Sara Keeble from Sterne Kessler analyze how patents with claims directed to medical treatments are handled in the US and in Europe.

16 Oct 2024 -

Women´s IP World Podcast, Episode 2 in Season 4

Our partner Dr.-Ing. Sophie Ertl gives a deep insight in her article from The Women's IP World Annual 2024, which provides a comparative analysis ...

10 Oct 2024 -

Patent revocation actions under the new European patent system: UPC vs. EPO and why it may be wise to reappraise your European filing strategy, The Patent Lawyer Magazine September/October, 2024 (Page 22)

12 Sep 2024 -

Die Marktexklusivität als absolutes Recht (Teil II), GRUR 16/2024

Wenngleich die arzneimittelrechtliche Marktexklusivität bei sog. „orphan drugs“ (Arzneimittel für seltene Leiden) und der verwandte nicht-indikationsbezogene Unterlagen- und Vermarktungsschutz einen zentralen Baustein für die Gewährleistung eines Investitions- und In...

27 Aug 2024 -

Wündisch/Zirkel, F&E-Verträge, Handbuch für Wissenschaft und Praxis, 2024 (German only)
Chapter on the Unified Patent Court and Unitary Patent and on the special features of research and development in the pharmaceutical and life sciences sector

Our colleague Dr. Marco Stief has been given the honor of contributing the chapters on the Unified Patent Court and Unitary Patent as well as on t...

12 Aug 2024 -

Judgment of the Italian Supreme Court on the so-called Bolar Exemption, 2024 (avialable in English)

12 Aug 2024 -

Podcast – Empowering women and nurturing young talent: Maiwald’s commitment to equality and diversity, MIP, 2024

Five female patent attorneys at Maiwald, spanning several age groups and practice areas, explain how the intellectual property firm encourages the career development of women and talented young professionals.

4 Jul 2024 -

Is the medical use disclosure standard different for novelty and sufficiency?, Managing IP, 2024

Eva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling relating to the standard of disclosure concerning the novelty and sufficiency of a therapeutic effec...

5 Jun 2024 -

Promoting women and young talent at MAIWALD, 2024

Maiwald, a leading German IP law firm, has 45% female partners, emphasizing equality and diversity. The firm supports women's career advancement and attracts talented women through its inclusive culture. Clients, even in m...

3 Jun 2024 -

Offshore wind power and territoriality principles from a German viewpoint, Managing IP 2024

Claus Schindele considers the legal complications regarding patent protection in the offshore wind sector, with a particular eye on Germany and the UK Patent protection in the offshore wind energy sector i...

31 May 2024 -

Die Marktexklusivität als absolutes Recht (Teil I), GRUR 11/2024

Investment and innovation protection are closely linked in the pharmaceutical sector for the development and marketing of new medicinal products. In addition to patent protection, market exclusivity under pharmaceutical law, which creates a legally defined protection period ...

24 Apr 2024 -

Unlocking Intellectual Property Efficiency: A comparative analysis of the EP patent, the DE patent, the German Utility Model, and the Unitary Patent, Women´s IP World annual, 2024

16 Apr 2024 -

European Parliament addresses thorny issue of plants generated by new genomic techniques, Managing IP 4/2024

In her article published by Managing IP, Kerstin Wolff reports on a proposal approved by the European Parliament (EP) that support...

15 Apr 2024 -

Wettbewerbsrecht im Kontext von Technologietransfer- und Lizenzverträgen, PharmR 4/2024

EU competition law in the context of technology transfer, license and settlement agreements: Since at least the initiation of the first pharma sector inquiry in 2008, the pharma industry has been under close and austere scrutiny of the EU Commission. In the first part of thi...

28 Mar 2024 -

Reliance on a purported technical effect for inventive step – Quo vadis “plausibility” after G 2/21? epi Information, 1/2024

In the context of the effect-driven assessment of inventive step under the European Patent Convention (EPC) it is usually crucial for the outcome whether an Applicant/a Patentee can rely on a specific technical effect corresponding to an improvement over the prior art. In th...

18 Mar 2024 -

Not without my consent – Zu den Grenzen des SPC squatting, GRUR 6/2024

SPC for pharmaceutical products are an important complement to patent protection which is often inadequate in commercial terms. SPCs are designed to ensure that originators can amortize their high investments in research and clinical trials. But unlike in the USA, for exampl...

13 Mar 2024 -

Wettbewerbsrecht im Kontext von F&E- und Linzenzverträgen, PharmR 3/2024

In the trade journal Pharma Recht (46th year, 15 March 2024), Dr. Marco Stief deals with the competition law assessment of research, cooperation and development agreements, with special consideration of the Research and Development Block Exemption Regulation.

5 Mar 2024 -

§ 945 ZPO – Ausweitung der Haftung der Originatoren bei später widerrufenem Patent?, GRUR 4/2024 (Stief/Meyer)

In a recent article published in GRUR 2024, 182 et seqq., Dr. Marco Stief and

5 Mar 2024 -

Products eligible for the medical use format under the EPC: new insights, Managing IP 2024

In the latest article published by Managing IP, Dr. Eva Ehlich and Dr. Anja Fux summarise an EPO board ruling relating to substances and compositions in the contex...

22 Jan 2024 -

T 0116/18 and a review after 10 months of G 2/21, Managing IP 2024

Decision on inventive step casts new light on EBA’s ‘plausibility’ guidance - Dr. Eva Ehlich and Dr. Anja Fux talk about this in the latest article on Managi...

21 Dec 2023 -

Rechtshandbuch Chemie-, Pharma- und Life-Science-Patente, C.H. Beck – 2023

Rechtshandbuch Chemie-, Pharma- und Life-Sciences-Patente is a comprehensive guide to the law on chemical, pharmaceutical and life sciences patents, which

21 Dec 2023 -

(No) injunctive relief before the actual grant of a patent, GRUR 23/2023

Following expiry of market exclusivity in March 2022 for the drug Gilenya® (active ingredient: fingolimod) used for the treatment of multiple sclerosis and an unexpected delay in the grant of the dosage patent on a second medical use following complaint proceedings, several...

13 Dec 2023 -

Does current legislation provide for adequate compensation in cases of unjustified preliminary injunctions? Originator–generic conflicts in the context of patent infringement proceedings, Journal of Intellectual Property Law & Practice, 12/2023 (Stief/Geller)

An English, updated and improved version of the article written by Dr. Marco Stief and Dr. Anja Geller that was published in GRUR 2023, 931 ff. is now available on the website of the

7 Dec 2023 -

Maiwald makes the case for patent lawyers to learn something new: LiquidText, The Patent Lawyer (Annual 2024)

The Patent Lawyer Editorial Board looks back at 2023 to summarize key cases and developments by jurisdiction. Influenced by several years of use,

7 Dec 2023 -

Repeated trademark filings: EUIPO Board addresses ‘annoying’ practice, Managing IP 2023

In a recent article with the title "Repeated trademark filings: EUIPO Board addresses 'annoying' practice" published by Managing IP, Susanna...

17 Oct 2023 -

The springboard doctrine in the context of patent law – part two, Managing IP 2023

In concluding a two-part series on springboard injunctions, Dr Marco Stief takes a deeper dive to explain their require...

4 Oct 2023 -

The springboard doctrine in the context of patent law – part one, Managing IP 2023

In the first of two articles on the springboard doctrine, Dr Marco Stief explains how the protective effect of a patent can continue to have an im...

31 Aug 2023 -

European Unitary Patent Package: Introduction to the New System including Strategic Considerations, (September 2023) 133 Intellectual Property Forum 40

The creation of the unitary patent and the Unified Patent Court (“UPC”) heralds the beginning of a new era in patent law in Europe. The Agreement on a Unified Patent Court (“UPCA”) entered into force on 1 June 2023 when the new UPC finally began operations. The openi...

17 Aug 2023 -

European Commission proposes transferable data exclusivity vouchers to tackle the antimicrobial resistance crisis, Managing IP 2023

In a recent article published by Managing IP, Dr Marco Stief considers a regulatory proposal designed to promote antimicrobial R&D and addres...

31 Jul 2023 -

Ergänzende Schutzzertifikate für Arzneimittel, EuZW 2023, 643

On April 27, 2023, the European Commission presented four proposals for Regulations on supplementary protection certificates as part of the Intellectual Property Action Plan. In this article, Dr Gisela Grabow, toget...

30 Jun 2023 -

Ersatzansprüche bei ungerechtfertigten einstweiligen Verfügungen im Pharmabereich – Ansprüche des Antragsgegners und geschädigter Dritter, GRUR 13/2023

Preliminary injunctions orders are commonly granted for pharmaceutical patents. If an order later proves to be unfounded, under § 945 German Code of Civil Procedure (ZPO) the defendant generic company can claim damages on the basis of the plaintiff's strict liability. Howev...

22 Jun 2023 -

A path towards a crisis-proof EU pharmaceutical legislation? The European Commission proposal, MIP 2023

On April 27 2023, the European Commission presented a proposal for the reform of the general pharmaceutical legislation in the EU. The proposal is based on

5 Jun 2023 -

Quo vadis Arzneimittelrecht – ein Überblick zur Überarbeitung der EU-Arzneimittelvorschriften, PharmR 6/2023

On April 27, 2023, the EU Commission presented a proposal for the reform of the pharmaceutical legislation in the EU. The proposal would lead to broad and far-reaching changes to the Regulation and the Directive, providing, for example for variable protection periods (standa...

16 May 2023 -

Der texanische “Two-Step”- Umstrittene juristische Strategie zur Begrenzung der Unternehmenshaftung, Arzneimittel & Recht 2/23

by Dr Marco Stief Since 1989, it has been possible under Texas law to divide a business corporation into individual entities by way of a so-called "divisive merger"...

25 Apr 2023 -

Decision on cease-and-desist declarations according to the ‘Hamburg custom’, MIP 2023

In its judgment of December 1 2022 (Case No. I ZR 144/21), the German Federal Court of Justice (FCJ) clarified several important points, which Dr Christian Meyer discusses in more detail in his article. Firstly, t...

21 Mar 2023 -

The role of patent attorneys in patent infringement disputes in Germany and Europe, MIP 2023

In the article "The role of patent attorneys in patent infringement disputes in Germany and Europe", published by Managing IP, Dr-Ing. Bo-Hyun Lee considers how the Unified Patent Court will affect the successful Germ...

21 Mar 2023 -

Interview on the UPC in the magazine “Die Welt” – Smart Rechtsguide, 2023

In the issue (No. 57) of "die Welt", Dr.-Ing. Sophie Ertl answered questions about the UPC as part of the supplement "Smart Rechtsguide": "Unitary Patent and Unitary Patent Court - what you need to know".

20 Mar 2023 -

EuGH: Plattformbetreiber haften für Markenrechtsverletzungen durch Drittanbieter – der Fall Louboutin/Amazon, BetriebsBerater 12/2023

In the contribution in the 12/2023 issue of the BetriebsBerater journal, Dr Marco Stief reports on a ruling by the ECJ that significantly extends the liability of online platforms for third-party trademark infringemen...

20 Mar 2023 -

Focus on: Anmeldeverfahren und Anmeldungen “Nicht immer ohne unerwünschte Nebenwirkungen – Einwendungen Dritter im Prüfungsverfahren vor dem Europäischen Patentamt”, Legal500.de, 2023

Nicht immer ohne unerwünschte Nebenwirkungen – Einwendungen Dritter im Prüfungsverfahren vor dem Europäischen Patentamt: In seinem allgemeinen “Auftrags”-Statement verweist das Europäische Patent...

15 Mar 2023 -

Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 2, PharmR 3/2023

With the Second Act on the Simplification and Modernization of Patent Law (2nd PatMoG), German patent law has undergone significant changes. In particular, in §139 (1) S.3 PatG a proportionality barrier with regard to the right to injunctive relief under patent law was codi...

1 Mar 2023 -

Pharmaceutical, Biological and Chemical Patents, C.H.BECK – 2023

by Prof. Dr Maximilian W. Haedicke, Dr Marco Stief and Dr Annelie Wünsche The subjec...

28 Feb 2023 -

Louboutin v Amazon: direct liability of online platforms for third-party trademark infringement, MIP 2023

In a recent article, published by MIP, Dr Marco Stief reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners.

27 Feb 2023 -

Die Einführung eines neuen Patentsystems in Europa, Betriebs-Berater 2023, Heft 09

by Dr Marco Stief It is official: On 17.2.2023 Germany has now also ratified the Agreement on a Unified Patent Court (UPC) and thus the start of the new Unified Pat...

15 Feb 2023 -

Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 1, PharmR 2/2023

On August 17, 2021, the Second Patent Law Simplification and Modernization Act (2nd PatMoG) was proclaimed, resulting in several changes for patent law. In the article "Der patentrechtliche Verhältnismäßigkeitsgrundsatz im Bereich Arzneimittel und Medizinprodukte, Teil 1 ...

30 Jan 2023 -

No-challenge and pay-for-delay agreements in patent licence and settlement agreements under European competition law, Journal of Intellectual Property Law & Practice, Vol. 18/2, 02/2023, S.135–145

In the article "No-Challenge and Pay-for-delay Agreements in Patent License and Settlement Agreements under European Competition Law," recently published by the Journal of IP Law & Practice (Oxford University Press), ...

26 Jan 2023 -

Europe’s new Unitary Patent System will affect IP Agreements, Law360 2023

by Dr Marco Stief The introduction of the European patent and court system is causing significant upheaval and requires owners of European patents to take precautio...

17 Jan 2023 -

Die Reform der Gruppenfreistellungsverordnungen – FuE- und Spezialisierungs-GVO 2023, Wirtschaft und Wettbewerb 01/2023

by Dr Marco Stief with Dr Anna Giedke, Dipl. jur. Selina Stachowitz With effect from 1 January 2023, new versions of the R&D- and Specialisation-BER should...

10 Jan 2023 -

IP as a means of securing a loan under German law, Managing IP 2023

Intellectual property can be utilised commercially in many ways. In addition to the traditional forms – such as the granting of licences, selling, and the judicial enforcement of cease-and-desist orders and claims for damages – IP can also be used as collateral for loans...

23 Dec 2022 -

Interview IAM Strategy 300 Global Leaders, 2023

This year IAM has once again invited top IP strategists to tell readers more about their careers in intellectual property, top lessons learned along the way and their views on the current state of the market. Like IAM Global Leaders, which features top-ranked private practic...

12 Dec 2022 -

Proportionality defence v compulsory licence: the decision of the Düsseldorf court, Managing IP 2022

Dr Marco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection of disproportion...

10 Nov 2022 -

IP Due Diligence und Pharma, |transkript 4-2022 im November – Spezial: “Patente / M&A / Lizenzierung”

Market leaders in the life sciences are interested in acquiring start-ups in order to acquire a new technology as soon as their investment risk can be better foreseen. In order to minimise the associated risks, a precise IP due diligence is required on the acquirer's side. I...

2 Nov 2022 -

JUVE Handbook 2022/2023: Co-publishing article on the topic of “Die Äquivalenz in der Patentverletzung: Neue Rechtsprechung”

In the current edition of the JUVE Handbook for Commercial Law Firms 2022/2023 published in October 2022 Dr Marco Stief,

24 Oct 2022 -

Preisanpassungsklauseln bei Verträgen zwischen Unternehmen, Betriebs-Berater 43/2022

In this article, Dr Marco Stief discusses the admissibility of value maintenance and price adjustment clauses in commercial contracts. After many years of relative...

19 Oct 2022 -

Einheitspatent und einheitliches Patentgericht – Vorstellung des neuen europaweiten Patent- und Gerichtssystems, PharmaR Heft 10/2022

In their contribution, Dr Marco Stief and Heike R...

10 Oct 2022 -

ECJ ruling brings clarity on the interruption of forfeiture periods, Managing IP 2022

Susanna Heurung examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs

29 Sep 2022 -

Recent ECJ case law and latest referrals for preliminary rulings on the SPC Regulation, IAM 2022

by Dr Derk Vos The contribution highlights recent ECJ decisions regarding Article 3(a) of the SPC Regulation relating to one of the core aspects of SPCs – namely, th...

19 Sep 2022 -

Germany cancels agreement with Switzerland on the use of trademarks, 2022

In the September edition of Managing Intellectual Property Susanna Heurung explains that owners of German trademarks who rely on their use in Switzerland must change their...

16 Aug 2022 -

Ergänzende Schutzzertifikate – Überblick und Ausblick zur EU-Initiative, Arzneimittel & Recht, 2022

SPCs are currently based on Regulation (EC) No. 469/2009 on the supplementary protection certificate for medicinal products. Under a current EU initiative, the Commission is proposing, among other things, a single granting procedure and a single SPC system. In order to be ab...

28 Jul 2022 -

Do the experimental use and bolar exemptions also apply in contributory patent infringement cases? Journal of Intellectual Property Law and Practice, 2022

The reach of Sec. 10(3) of the German Patent Act (GPA) has been the subject of debate by German patent courts for many years. Final clarification by the German Supreme Court is still awaited on the extent to which third parties are liable for their own supplying acts which d...

12 Jul 2022 -

The biggest change is the introduction of a right to compensation under unfair competition law for consumers, 07/2022

In the Special Report of Leaders League, Dr Christian Meyer explains how the new claim for compensation, based on the Directive (EU) 2019/2161 of 27 November 2019 on consu...

11 Jul 2022 -

Patents: New principles in preliminary injunction proceedings, 2022

In the July edition of Managing Intellectual Property Heike Röder-Hitschke discusses a significant European Court of Justice (CJEU) ruling, and how it will affect future practice in preliminary injunction pr...

28 Jun 2022 -

EU-Initiative zu Zwangslizenzen – Chance oder Wettbewerbsnachteil? Arzneimittel & Recht, 2022

In an article just recently published in the journal Arzneimittel & Recht (Edition 03/22) Dr Gisela Grabow and Dr Marco Stief discuss the grant ...

23 Jun 2022 -

Originator vs. Generics – Pharmaceutical patents in the context of PI proceedings – latest developments and trends in German patent infringement litigation, PharmR 6/2022

In the latest issue of Pharma Recht, Dr Marco Stief and Dr Christian Meyer review and summarise the rather game-changing legal and factual developments in ...

9 Jun 2022 -

Patents: New Principles in preliminary injunction proceedings – in: BioScience Law Review, vol. 18 issue 5 (06, 2022)

In her publication "Patents: New Principles in preliminary injunction proceedings",

16 May 2022 -

A quiet but important step for software patents in Germany, 2022

Dr Simon Lud explains in Managing Intellectual Property how a German court judgment is advantageous for patent applications in the fields of artificial intelligence and quantum computing.

26 Apr 2022 -

Haftungsbegrenzungen und Freistellungsvereinbarungen insbesondere in Technologie- und Unternehmenskaufverträgen (M&A), Lizenz- und F&E-Verträgen, 2022

In the second part of the recently published article on contractual IP warranties, Dr Marco Stief discusses (1) limitations and restrictions of liability and (2) contractual indemnification obligations, both in the co...

30 Mar 2022 -

Vertragliche IP Garantien in Pharmaverträgen, insbesondere M&A, Lizenz und F&E Verträge, 2022

In the current issue of PharmR, Maiwald partner Dr Marco Stief takes a close-up look at contractual IP warranties, more specifically in the context of contracts regarding M&A, licensing, and research and developme...

24 Mar 2022 -

Clarification on the transfer of priority rights expected at the EPO, 2022

Dr Matthias Hoffmann discusses in Managing Intellectual Property the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO.

20 Jan 2022 -

USB stick meets sufficiently specific test in Germany, 2022

Dr Christian Meyer discusses in a publication of Managing Intellectual Property a case concerning the domain muenchen.de, in which a reference to a USB stick was found to ...

2 Nov 2021 -

2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)”

We are delighted to announce the release of the 2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)” edited by our partner Dr. Marco Stief. The book provides a detailed insight into t...

2 Nov 2021 -

JUVE Handbook 2021/2022: Co-publishing article on the topic of „Chancen und Stolpersteine bei Videoverhandlungen am EPA“

In the current edition of the JUVE Handbook for Commercial Law Firms 2021/2022 published in October 2021 Dr Eva Ehlich,

28 Oct 2021 -

New referral to the EBoA: post-filed experimental evidence and plausibility, 2021

by Dr Stefanie Parchmann i...

27 Oct 2021 -

Alignment of Pharmaceutical Strategy for Europe with the Action Plan on IP, 2021

by Dr Gisela Grabow in Managing Intellectual Property

26 Oct 2021 -

Admissibility of non-challenge clauses and pay-for-delay agreements in settlements and license, 2021

by Dr Marco Stief In the current October issue of Pharma Recht - a specialist journal for pharmaceutical law our partner Dr. Marco Stief has written an article with...

14 Oct 2021 -

Das Versuchs- und Bolar-Privileg im Bereich der mittelbaren Patentverletzung, 2021

by Dr Marco Stief and

1 Sep 2021 -

German Court Calls for Better Enforcement of Preliminary Injunctions in Patent Infringement Case, 2021

by Dr Christian Meyer in Managing Intellectual Property

1 Aug 2021 -

Enlarged Board of Appeal Rules on Double Patenting, 2021

by Dr Annelie Wünsche and Dr Stefanie Parchmann

1 Aug 2021 -

Vertragshandbuch Pharma und Life Sciences, C.H.BECK, 2., erw. Auflage – 2021 (gemeinsam hrsg. mit Boris Bromm)

by Dr Marco Stief and Boris Bromm The current manual offers a comprehensive collection of annotated contra...

1 Jun 2021 -

Wir helfen dem Erfinder, seine Idee zu schützen, 2021

by Dr Sophie Ertl in ZEIT „Arbeitswelten der Zukunft“

1 May 2021 -

Patente treiben Innovation und Fortschritt, 2021

by Dr Eva Ehlich and Dr Christian Schäflein in Smart Rechtsguide 2021

1 May 2021 -

Germany: EBA Set to Hear Case on the Legality of the EPO’s Video Proceedings, 2021

by Dr Eva Ehlich and Angela Zumstein

1 May 2021 -

Connected Cars, SEP and Frand-Cjeu Referral With a Focus on Multi-Tier Supply Chains, 2021

by Dr Marco Stief and Heike Röder-Hitschke in Journal of Intellectual Property Law & Practice

1 May 2021 -

CJEU SANTEN: No More SPC protection for new indications and new galenic formulations? (2021)

by Dr Marco Stief and Dr Robert Wenzel in Journal of Intellectual Property Law & Practice

25 Apr 2021 -

EPA: Videoconferencing at the EPO – Springboard Into a Digital Age

�...

1 Apr 2021 -

Videoconferencing at the EPO – Springboard Into a Digital Age?

1 Apr 2021 -

Admissibility of Second Infringement Action Based on the Same Patent, but Different Infringing Act

by Damla Simsek and Dr Stefanie Parchmann

28 Jan 2021 -

The launch of Horizon Europe: The EU initiative for research and innovation, 2021

by Dr Marco Stief in Managing Intellectual Property

7 Jan 2021 -

German court rules against automated dispensing of medicinal products, 2021

by Dr Christian Meyer in Managing Intellectual Property

23 Nov 2020 -

Recent amendments to the SPC Regulation, 2020

by Dr Derk Vos in IAM Innovation & Invention Yearbook: Building IP value in the 21st century This article first appeared in IAM Innovation & Invention Yearbook: Building IP value i...

29 Oct 2020 -

Schutzzertifikat widerrufen, 2020

by Dr Derk Vos in transkript - Life Science Magazine

21 Oct 2020 -

Protection Through Insurance Solutions

by Dr Christian Pisani (together with Rebecca Koch) in Risikomanagement, Organisation, Compliance für Unternehmen Eds. Zenke / Schäfer / Brocke

6 Oct 2020 -

Das Ende von SPCs für neue Indikationen? (2020)

by Dr Marco Stief in the GRUR - Zeitschrift der Deutschen Vereinigung für gewerblichen Rechtsschutz und Urheberrecht

28 Sep 2020 -

Case provides legal certainty for employers and employee inventors, 2020

by Dr Anja Friedrich in Managing Intellectual Property

14 Sep 2020 -

Lieferengpässe in der Arzneimittelindustrie – Ursache, Gründe und Lösungsansätze am Beispiel des Corona Virus (Teil 2), 2020

by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht

10 Jul 2020 -

Distinguishing Between a Technical Feature and a Representation of Information, 2020

by Stefan Bianchin in Managing Intellectual Property

1 Jul 2020 -

EMA and EU Commission offer flexibility instead of intervention, 2020

by Dr Gisela Grabow in Managing Intellectual Property

16 Jun 2020 -

Lieferengpässe in der Arzneimittelindustrie – Ursache, Gründe und Lösungsansätze am Beispiel des Corona Virus (Teil 1), 2020

by Dr Marco Stief and Dr Boris Bromm in Pharma Recht - Fachzeitschrift für das gesamte Arzneimittelrecht

15 Apr 2020 -

Forum Shopping Is Becoming More Difficult, 2020

by Dr Annelie Wünsche in Managing Intellectual Property

15 Apr 2020 -

How are patents interpreted after nullity proceedings? (2020)

by Thomas Ederer in Managing Intellectual Property

25 Mar 2020 -

Handbuch des Patentrechts, 2. Auflage, 2020

2nd edition 2020 Eds. Haedecke / Timmann, edited i. a. by Dr Dirk Bühler and Dr Marco Stie...

31 Jan 2020 -

Rechtliche Probleme des ergänzenden Schutzzertifikats für Arzneimittel, 2020

Using the example of medical indications, excipients and combinations of active ingredients by Dr Marco Stief Publisher Carl Heymanns Verlag ISBN 97...

26 Nov 2019 -

Compliance Requirements for Effective Risk Management

by Elke Wurster and Dr Christian Pisani in MPJ - Medizinprodukte Journal

26 Nov 2019 -

CJEU Clarifies the Impact of a Declaration

by Stephan Schneller in Managing Intellectual Property

14 Nov 2019 -

Auch “kleinere” Ideen sind schützenswert, 2020

by Dr Eva Dörner and Alexander Ortlieb in Rechtsguide 2020 (insert of Süddeutsche Zeitung)

30 Oct 2019 -

German Federal Patent Court Releases New Decision, 2019

by Stefan Bianchin in Managing Intellectual Property

28 Oct 2019 -

AIPPI Study Question 2019 Plausability

by Dr Ina Bürck in Study Guidelines, 2019 AIPPI Word Congress - London additional authors: Heiko Dumlich, Johannes Gierlich, Robin Keulertz, Simon Klopschinski, Philipp Marchand, Michael Schneider, Stefan Sc...

9 Oct 2019 -

Protection of inventions in AI and digitalisation, 2020

by Dr Christian Schäflein and Dr Fabian Kiendl in IAM Yearbook: Building IP value in the 21st century 2020 T...

7 Oct 2019 -

FCJ Clarifies Requirements for Enforcement of Time-Barred and Non-Time-Barred Claims, 2019

by Dr Christian Meyer in Managing Intellectual Property

7 Oct 2019 -

Claim Interpretation If Preamble Equates to State of the Art

by Dr Volker Tegeder in Managing Intellectual Property

26 Aug 2019 -

General Court confirms lack of likelihood of confusion between IOS FINANCE and EOS

by Stephan Schneller and Samira Weik in World Trademark Review This article first appeared on WTR Daily, part of World Trademark Review, in (07/2019). For further information, please go to

25 Jul 2019 -